drugset / Trial / NCT02062203
Effect of AKB-6548 on Cardiac Repolarization Intervals in Healthy Volunteers
RandomizedCrossoverQuadruple-blindOther
Summary
The main purpose of this study is to evaluate the effect of single oral therapeutic and supratherapeutic doses of AKB-6548 on the QT interval.
Timeline
- Start
- 2014-01
- Primary completion
- 2014-04
- Completion
- 2014-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Moxifloxacin | Small molecule | 400 mg | Oral |
| Subject | Vadadustat | Small molecule | — | Oral |
Indications
No indication recorded.